News

Great success at the Sinergia 2022 Open Day

This Saturday, the Bellvitge Campus opened its doors to bring the research of one of the most important biomedical centers in the country closer to the public. With activities such as guided tours, talks, escape rooms, and gymkhanas the event had a great attendance success.

Leer más

A new study confirms that deep brain stimulation halves symptoms in severe OCD

This is the second largest sample of patients in the world, treated and followed up by a multidisciplinary team at Bellvitge since 2007. The results suggest that, in addition to reducing obsessive symptoms, the treatment reduces anxiety and depression in these patients.

Leer más

Researchers validate a microRNA as a biomarker for the diagnosis of azoospermia

A new study confirms the clinical utility of a test based on the quantification of miR-31-5p microRNA levels in semen as a non-invasive biomarker to distinguish the origin of azoospermia

Leer más

IDIBELL organized a meeting of breast cancer solidarity donors and associations

Yesterday, the breast cancer research team received associations and individuals who, thanks to their donations, have promoted research.

Leer más

The fourth edition of Sinergia arrives, the festival of health research and innovation of L’Hospitalet

Throughout the week of October 3rd to 8th, gymkhanas, talks, visits, and many other activities will bring science from the Bellvitge Campus closer to the public.

Leer más

Success of the second symposium of the Oncobell research program

This Monday and Tuesday, September 19 and 20, the second Oncobell Symposium was held in the auditorium of the Bellvitge University Hospital. Under the slogan “building bridges between science, medicine and people” the congress is a forum to discuss the latest advances in basic and clinical research with top-level cancer professionals

Leer más

IDIBELL researchers analyze the evidence of iron supplementation in chronic heart failure

They have shown that intravenous iron administration improves the quality of life and prognosis in patients with heart failure and ventricular dysfunction.

Leer más

The IDIBELL-Ins Bellvitge Tandem opens the academic year with the inauguration of new scientific instruments for the secondary school laboratory

During the academic year that is beginning, the Tandem will continue educational projects that have been successful in recent years, such as the production of Life & Science magazine, the European Stars Game project, the Women of Science series, or the implementation of new laboratory practices in charge of the URIB

Leer más

Access to quality medical and emotional information during breast cancer through digital platforms could reduce patient discomfort

Misinformation about the disease is one of the most stressful factors for patients. For this reason, creating quality content could help maintain emotional well-being.

Leer más
Scroll to Top